#NHOTC17: Day 2

OTCINACTION

This week we publish our second and final blog update on our 28th European OTC INSIGHT conference, which took place in Munich earlier this month and was centred on the theme of Making the Most of New Technology. Below is a quick round-up of proceedings on Day 2.

IMG_2162

Ed Rowland opens Day 2 proceedings

Ed Rowland opened the conference with an update on key drivers and dynamics in the US OTC strategic landscape. Akhil Chandra of Reckitt Benckiser led us into our final networking hour with a discussion on what makes an iconic brand in a world of biosimilar products. Chandra based his talk around the “iconicity” of Nurofen, insisting that when it comes to brands we should challenge the tendency to default, and instead create, identify and nurture iconic / symbolic elements.

Following an hour of networking with OTC peers, our delegates returned for our final session with Jesus Carrasco, Head of Healthcare at Société Générale, who discussed consolidation and the increasing attractiveness of the consumer healthcare industry from a corporate and investor perspective.

Screen Shot 2017-04-24 at 12.02.28

Thornsten Umland from Bayer gave the final presentation on strategic growth and how to build OTC businesses and brands via well executed acquisition and true product innovation.

And finally, a personal message from Nicholas: “Thank you all for making a brilliantly successful conference, the array of speakers and topics covered have certainly left us all with food for thought on the OTC landscape in a world of digital!

As an official announcement, now the conference has ended, we hope to see you next year in… BARCELONA for our 29th European OTC conference #NHOTC18. Auf Wiedersehen or should I say… Adios!”

Screen Shot 2017-04-24 at 12.03.52

Nicholas Hall’s Latin American conference: Day 1

Our special correspondent Holly Parmenter reports back on Day 1 proceedings at Nicholas Hall & Company’s 2nd Latin America conference in Miami, Florida.

With the theme of From Recession to Recovery: Analysing Latin America’s Return to Growth, the conference opened with Nicholas Hall’s update and annual report. The annual report discussed the recent OTC successes, and the changes and challenges impacting consumer health. Nicholas Hall focused on fast-growing categories such as the success of intranasal allergy sprays, OTC contraceptives and the implication of switch for erectile dysfunction treatments.

Nicholas Hall Miami

Key speakers of the day were Alonso Botero of Tecnoquimicas, who shared his views on the Colombian OTC market, explaining its monumental growth and how it has become the fifth fastest-growing country of the century.

Former General Manager of GSK Consumer Healthcare Brazil, Simone Torres Soares, gave a presentation on digital opportunities within OTC brand marketing and discussed how digital can impact our business model and change the OTC industry.

Ed Rowland, Founder and Managing Partner of Rowland Global LLC, covered the upside of devaluation and growth in Mexico stating that e-commerce is coming with a force, looking to drive growth in Mexico through social media in a 3-5 year timeframe.

Abbott Nutrition General Manager, Carlos Andrade, gave some perspective on the current economic crisis in Brazil, while also stating the country’s resilience.

Thorsten Umland, VP and Head, Business Development & Licensing Consumer Health, Bayer, concluded the presentations with a Global OTC M&A Landscape.

We will be bringing you a fuller, more in-depth report on proceedings in next week’s blog.

OTCs in Action Episode 53: Helping refugees

OTCinActionheader

In the giving spirit of the season, OTCs are in Action in Europe, where Bayer has been helping refugees. Last month, the company announced the donation of ointments, pain relievers and antibiotics worth more than US$1.5mn to aid organisations in Turkey, Greece and Austria.

Bayer also implemented educational programmes in Germany to help refugees assimilate into a new culture. “Integrating the refugees is one of the most important challenges facing our whole society at the moment. Bayer therefore intends to use a variety of means of ensuring that young refugees in particular are offered a perspective,” explains Bayer Labor Director, Michael König.

Already, 20 refugees have begun a foundation course at the Chempark Leverkusen site to prepare for vocational training. The course is fully financed by Bayer and organised by certified refugee aid providers. “The course will last a total of four months, with the goal of improving the language skills of the refugees, which are often not good enough for starting work, and providing the participants with initial career guidance,” explains Georg Müller, head of HR for Bayer in Germany.

20 junge Flüchtlinge beginnen bei Bayer einen viermonatigen Aufbaukurs zur Berufsvorbereitung.

Afterwards, the young refugees can complete a four-week practical internship at Chempark, and successful participants can apply for the regular Bayer pre-training programme which, from now on, will reserve a number of places for refugees wishing to receive vocational training. Bayer set up the pre-training programme over 25 years ago to prepare disadvantaged youngsters for later training in a science / technical profession.

Other initiatives include:

• Offering eight days of paid leave to employees volunteering with established aid organisations

• Partnering with the Berlin Senate to establish the “Science4Life” academy in Berlin to encourage science education among refugee children. To this end, Bayer’s foundation is investing more than US$400,000 in the education and future prospects of refugee children over the next five years

On a final note, the OTCs in Action team wishes our readers a healthy, safe and happy New Year!

Big Growth for the New Year – Nicholas Hall’s OTC INSIGHT Latin America

Cath INSIGHT Header 2014We have just published the January / February issue of OTC INSIGHT Latin America. Our Market Report focuses on Gastrointestinals and it has been a good year for the industry with each Big 4 country and all sub-categories posting growth. Lots of activity has been seen in antacids & antiflatulents where a flurry of innovative launches and line extensions have increased competition. Marketers are expanding their consumer base by extending brands into niche segments, such as Bayer’s Alka-Seltzer Boost in Mexico, positioned to relieve hangovers, while on-the-go line extensions from GSK and Hypermarcas in Brazil offer consumers convenience.

Continue reading